John E. Bisi

1 Patent

• US122854312025

  Treatment of Rb-negative Tumors Using Topoisomerase Inhibitors in Combination with Cyclin Dependent Kinase 4/6 Inhibitors

  Pharmacosmos Holding A/S

  0 cites